March 22, 2018 / 12:09 PM / 6 months ago

BRIEF-Takeda Announces Publication Of Final Data From Iclusig Pivotal Phase 2 Pace Trial In Blood

March 22 (Reuters) - Takeda Pharmaceutical Co Ltd:

* TAKEDA ANNOUNCES PUBLICATION OF FINAL DATA FROM ICLUSIG® (PONATINIB) PIVOTAL PHASE 2 PACE TRIAL IN BLOOD Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below